| 2026-01-23 | Regal Partners LimitedUnternehmen | -4,59M | 289,10k | Verkauf | 0,04 - 0,08 | 29,24M | -13,57% |
| 2026-03-06 | Mr. Chun Leung LaiFounder, MD, CEO & Executive Director | -210,08k | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-12-22 | Mr. Chun Leung LaiFounder, MD, CEO & Executive Director | 208,25k | 0,00 | Derivative Exercise and Retained Stock | - | 10,74M | 1,98% |
| 2025-12-22 | Mr. Chun Leung LaiFounder, MD, CEO & Executive Director | -1,67M | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-12-13 | Dr. Miles Gareth JakemanIndependent Non-Executive Chairman of the Board | -476,19k | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-12-13 | Mr. Chun Leung LaiFounder, MD, CEO & Executive Director | -119,05k | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-12-02 | Dr. Marcus ThompsonNon-Executive Director | 3,41M | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,06 | - | - |
| 2025-11-24 | Dr. Miles Gareth JakemanIndependent Non-Executive Chairman of the Board | -1.000,00k | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-07-08 | Mr. Kurt A. MueffelmannChief Strategy Officer & US President | 166,67k | 16,31k | Kauf | 0,10 | 19,15M | 0,88% |
| 2024-12-15 | Mr. Kurt A. MueffelmannChief Strategy Officer & US President | 846,06k | 0,00 | Acquisition Under Employee Benefit Plan | - | 19,15M | 4,62% |
| 2025-06-30 | Mr. Chun Leung LaiFounder, MD, CEO & Executive Director | 189,34k | 0,00 | Derivative Exercise and Retained Stock | - | 10,53M | 1,83% |